Breast-conserving surgery (BCS) stands as a highly effective treatment for early-stage breast cancer patients. Surgeons aim to achieve clear breast-conserving surgery margins, which strictly requires that no ink touches the tumor on the excised specimen. However, current clinical data suggests that nearly 15% to 35% of these patients require additional surgeries due to the presence of malignant cells at the margin. This high re-excision rate often leads to poorer cosmetic results and increased psychological distress for the patient.

Consequently, many medical experts are looking beyond traditional methods for assessing margins. For decades, clinicians relied on frozen section analysis or touch-preparation cytology. While these methods are standardized, they are also labor-intensive and time-consuming. Furthermore, they often require a high level of pathology expertise that may not be available in every surgical suite. Therefore, the search for more efficient, real-time diagnostic tools has accelerated.

Innovative Technologies for Evaluating Breast-Conserving Surgery Margins

Emerging technological approaches are now gaining significant attention within the surgical community. For instance, new imaging devices such as wide-field optical coherence tomography (OCT) provide high-resolution, microscopic views of the tissue in real-time. Additionally, the integration of artificial intelligence (AI) helps surgeons identify suspicious areas with greater precision than ever before. These AI-enabled systems can analyze millions of tissue images to flag difficult-to-detect cancer cells immediately during the procedure.

Moreover, the development of molecular probes represents another major research direction for the future. These probes target specific markers on cancer cells, allowing them to "light up" under specialized imaging systems. This molecular-level navigation ensures that surgeons can preserve more healthy tissue while ensuring the complete removal of the tumor. Ultimately, collaboration between oncology specialists, bioengineers, and radiologists is essential to reducing positive margin rates and improving long-term recurrence outcomes.

Frequently Asked Questions

1. Why are clear breast-conserving surgery margins so important?

A clear margin, defined as "no ink on tumor," significantly reduces the risk of local recurrence. If margins are positive, patients often need a second surgery to ensure all cancerous tissue is removed.

2. How does AI improve intraoperative margin assessment?

AI-enabled systems use advanced algorithms to evaluate high-resolution images of the excised tissue. This provides the surgical team with instant feedback, allowing them to re-excise suspicious areas before the initial operation concludes.

3. What are the limitations of traditional frozen sections?

Frozen sections are resource-intensive and can cause tissue artifacts. Additionally, they only sample specific areas of the margin, which might miss focal clusters of malignant cells in other parts of the specimen.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

• Chen WL et al. Intraoperative measurement of breast-conserving surgery margins: surgical application. Breast Cancer Res. 2026 Jun 05. doi: 10.1186/s13058-026-02316-6. PMID: 42249516.


• Perimeter Medical Imaging AI. FDA Awards Premarket Approval to AI-Enabled Imaging Device for Breast Cancer Surgery. Targeted Oncology. 2026 Mar 04.


• Frontiers in Oncology. Enhancing precision in breast conserving surgery: introduction to emerging imaging technologies. 2026 Mar 26.